We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00727623
Recruitment Status : Recruiting
First Posted : August 4, 2008
Last Update Posted : August 9, 2016
Belgian Government
Information provided by (Responsible Party):
M Claeys, Universiteit Antwerpen

Brief Summary:
The purpose of this observational study is to assess predictors of in-hospital mortality in patients with acute myocardial infarction admitted to Belgian hospitals.

Condition or disease
Acute Myocardial Infarction

Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Observational Study to Assess Predictors of in Hospital Mortality in STEMI Patients Admitted in Belgian Hospitals
Study Start Date : July 2007
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack
U.S. FDA Resources

Primary Outcome Measures :
  1. all cause mortality [ Time Frame: one month ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with acute ST elevation myocardial infarction admitted in Belgian hospitals.

Inclusion Criteria:

  • clinical diagnosis of acute myocardial infarction with ST elevation or left bundle branch blok pattern on ECG

Exclusion Criteria:

  • acute myocardial infarction as an acute complication of coronary intervention

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00727623

Contact: Marc J Claeys, MD PhD 3238214706 marc.claeys@uantwerpen.be
Contact: Christiaan M Vrints, MD PhD 3238214720 christiaan.vrints@ua.ac.be

Centre Hospitalier de Jolimont Recruiting
La Louviere, Hainaut, Belgium, 7100
Contact: Antoine de Meester, MD    32 64 233011    antoine.demeester@skynet.be   
Sponsors and Collaborators
Universiteit Antwerpen
Belgian Government
Principal Investigator: Marc J Claeys, MD.PhD University Hospital, Antwerp

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: M Claeys, Prof dr, Universiteit Antwerpen
ClinicalTrials.gov Identifier: NCT00727623     History of Changes
Other Study ID Numbers: BIWAC-01
First Posted: August 4, 2008    Key Record Dates
Last Update Posted: August 9, 2016
Last Verified: August 2016

Keywords provided by M Claeys, Universiteit Antwerpen:
acute coronary syndrome
myocardial infarction
predictors of mortality
reperfusion therapy

Additional relevant MeSH terms:
Myocardial Infarction
ST Elevation Myocardial Infarction
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases